Business Wire

OT and Etisalat Join Forces to Launch Internet of Things Services in Egypt


Oberthur Technologies (OT), a leading global provider of embedded security software products, services and solutions, today announces its collaboration with Etisalat Misr, a leading Telecommunications service provider, to launch M2M and IoT services. Relying on OT’s M-Sense solution, a cutting edge software platform enabling fast service deployment, Etisalat Misr will enable its Enterprise customers to quickly launch new M2M and IoT services.

This partnership is a concrete outcome of the Frame Agreement signed between OT and Etisalat Group (Abu Dhabi) in July 2015. The project aims to deliver a tailored and modular solution enabling selected local ecosystem partners to leverage the platform’s ready-made components and use existing application frameworks. These components include sensor data visualization, reporting, business rules and off-the-shelf applications in order to further build customized applications.

OT’s reactivity to develop and propose a scalable commercial configuration has been a critical element in Etisalat’s decision. Indeed, the full platform serving the initial priority projects and selected IoT Services will be available in a short timeframe.

Etisalat Misr has selected OT’s M-Sense platform, powered by Cumulocity, the leading software provider of IoT application enablement and device management (source: MachNation December 2015 IoT Report), for its rich set of horizontal capabilities for both application enablement and device management. M-Sense allows easy and fast device integration over any network. It secures collection, visualization and real-time management of various IoT data from any M2M device and controls remotely connected enterprise assets in real time. OT’s M-Sense solution will enable Etisalat to accelerate the deployment of vertical applications, whether they are for Smart Cities, Universities or enterprises operating in the Transport, Oil and Energy or Real Estate sectors, to name but a few.

“OT has been a long-term partner for Etisalat, already supplying Etisalat with both SIM cards and secure mission-critical software platforms. Moving from quality of service era to quality of life one is our approach in Etisalat Misr. Our IoT solutions will dramatically improve energy efficiency, security, logistics, education and many other aspects of everyday things”,said Khaled Rabie CBO at Etisalat Misr, adding “OT’s solution for IoT application enablement and M2M device management will help us to drive our IoT strategy, test innovative concepts and build the many value-added services the market is looking for and that we are willing to bring to our potential customers.”

We are extremely happy to partner with Etisalat Misr to have a rich portfolio of M2M and IoT applications and services, and increase the benefits for their Enterprise customers. As OT’s M-Sense is an open and standardized platform, Etisalat customers will get access to a wide range of tools and software components and they will be able to quickly develop and launch a large portfolio of innovative M2M and IoT applications” said Arnaud de La Chapelle, OT’s RMEA President.


OT is a world leader in embedded digital security that protects you when you connect, authenticate or pay.

OT is strategically positioned in high growth markets and offers embedded security software solutions for “end-point” devices as well as associated remote management solutions to a huge portfolio of international clients, including banks and financial institutions, mobile operators, authorities and governments, as well as manufacturers of connected objects and equipment.

OT employs over 6 300 employees worldwide, including almost 700 R&D people. With a global footprint of 4 regional secure manufacturing hubs and 39 secure service centers, OT’s international network serves clients in 140 countries. For more information:


Etisalat, the leading emerging markets telecom group, is headquartered in Abu Dhabi. Since its inception almost four decades ago, Etisalat has been introducing innovative connectivity solutions for its customers across the Middle East, Asia and Africa. These cutting-edge solutions have given Etisalat the ability to expand its subscriber base to more than 173 million in the 19 international markets it operates in. Etisalat’s market cap is 96.8 billion AED, equaling 26.4 billion USD.


Etisalat Misr from launch to date has maintained technology leadership and serves millions of customer across Egypt with the best quality of products and services making it a market leader in the telecom industry in Egypt and aiming to “Become the ICT provider of choice in the Egyptian telecom market”. Etisalat believes in innovation and under the slogan “A New Day A New ideas” customers are provided by daily below the line campaigns and promotions. Also focusing and addressing the enterprise segment demands in the Egyptian market.

Download  The M World ,
All you need to know about the latest trends of the Mobility world, available on AppStore and Google Play


Contact information

Oberthur Technologies
Magali Gabuet-Hamonic, Tél. : +33 1 78 14 76 75
Hadrien Le Roux / Elise Cognacq, Tél. : +33 1 86 21 50 83 / +33 1 86 21 50 67 /

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on